RESEARCH TRIANGLE PARK – On Monday, Feb. 26, as a prelude to the 26th Annual CED Life Sciences Forum, the North Carolina Biotechnology Center (NCBC) and The Center of Innovation Network (COIN) will be hosting a special forum focused on Biomanufacturing in North Carolina.
North Carolina’s Life Sciences Sector runs deep and wide across the State. Over 650 life sciences companies contribute over $86B to the North Carolina economy with 63,000 employees and direct payroll of $6.6B. Indirectly, the industry impacts over 260,000 employees and provides over $2.2B in State and Local taxes to our economy. A significant number of the industry’s workers work in the advanced manufacturing facilities that provide life-saving medicines and devices to the world.
Often overlooked is the fact that in the past few years global biotech companies in North Carolina, including Novo Nordisk, Grifols, Pfizer, and others will invest over $3B in advanced biomanufacturing facilities and add thousands of new jobs both directly within the facilities and, not-to-be overlooked, in the companies that serve these facilities.
Our panelists at this Forum will discuss their plans for growing their advanced manufacturing capabilities and what they see as the future of biomanufacturing in North Carolina, which is the 3rd largest biomanufacturing cluster in the US. They’ll also discuss their manpower needs and how our Universities and National Initiatives such as NIIMBL (The National Institute for Innovation in Manufacturing Biopharmaceuticals) are helping them continue to grow and positively impact our economy and global health. NIIMBL is a public-private consortium dedicated to advancing biopharmaceutical manufacturing innovation.
Confirmed Speakers include: